Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
Hypoxia is a hallmark of glioblastoma multiforme (GBM), the most aggressive cancer of the central nervous system, and is associated with multiple aspects of tumor pathogenesis. For example, hypoxia induces resistance to conventional cancer therapies and inhibits antitumor immune responses. Thus, tar...
Main Authors: | Jang Hyun Park, Heung Kyu Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/5/1176 |
Similar Items
-
Editorial: Improving responses to immunotherapy in glioblastoma multiforme
by: Stephanie E. B. McArdle, et al.
Published: (2024-04-01) -
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
by: Joshua R. D. Pearson, et al.
Published: (2020-10-01) -
Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
by: Andrea eSchuessler, et al.
Published: (2014-10-01) -
Current Immunotherapies for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2021-03-01) -
The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma
by: Luigi eSforna, et al.
Published: (2015-01-01)